These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3509365)

  • 41. Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
    Fu HG; Hu XX; Li CR; Li YH; Wang YX; Jiang JD; Bi CW; Tang S; You XF; Song DQ
    Eur J Med Chem; 2016 Mar; 110():151-63. PubMed ID: 26827160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro activity of aztreonam, cefoperazone and ceftriaxone against gram-negative bacteria].
    Baykal M; Hasçelik G
    Mikrobiyol Bul; 1990 Jul; 24(3):248-50. PubMed ID: 2283976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Resistance of gram-negative bacilli to 6 aminoglycosides].
    Broussain MT; Pinto ME; Cona E
    Rev Med Chil; 1985 Dec; 113(12):1210-6. PubMed ID: 3016857
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivatives.
    Cascio G; Lorenzi L; Caglio D; Manghisi E; Arcamone F; Guanti G; Satta G; Morandotti G; Sperning R
    Farmaco; 1996 Mar; 51(3):189-96. PubMed ID: 8688141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Rapid method for determining the drug resistance of gram-negative bacteria].
    Pavlov A; Markarian M
    Vet Med Nauki; 1985; 22(1):36-9. PubMed ID: 3992915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergic activity of beta-lactamines and aminoglycosides vs. bacterial strains treated with sub-MIC concentrations.
    Gismondo MR; Romeo MA; Pappalardo C; Puglisi G; Leonardi R
    Chemioterapia; 1984 Jun; 3(3):175-7. PubMed ID: 6529773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteria.
    Smith RP; Baltch AL; Hammer MC; Conroy JV
    Clin Ther; 1986; 9(1):106-18. PubMed ID: 3815456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vitro activity of eight antibiotics against Pseudomonas aeruginosa and infrequently isolated gram-negative bacilli.
    Chiaradia V; Pascoli L; Santini G
    Chemioterapia; 1985 Aug; 4(4):284-8. PubMed ID: 3931923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative in vitro activity of ciprofloxacin and other antimicrobial agents against aminoglycoside-resistant gram-negative rods and microorganisms isolated from patients with bacteremia.
    Weinstein MP
    Chemotherapy; 1986; 32(5):446-52. PubMed ID: 3757586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro study of the sensitivity of 1030 hospital-isolated bacterial strains to aztreonam.
    Grassi L
    Chemioterapia; 1984 Aug; 3(4):262-6. PubMed ID: 6543433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [In vitro activity of azthreonam (SQ 26.776) against Gram-negative bacteria].
    Landínez RJ; García Castro MA; Coladas N; Bratos MA; Kastanos N; Alvarez Alonso E
    Med Clin (Barc); 1984 Jan; 82(3):106-9. PubMed ID: 6431206
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antibiotic sensitivity of gram negative bacilli isolated from urinary tract infections at NUHC of Cotonou (Benin) from March to December 1992].
    Anagonou SY; Eslahpazire J; Makoutodé M; Josse R; Massougbodji A; Sadeler BC
    Bull Soc Pathol Exot; 1994; 87(4):223-5. PubMed ID: 7866038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbiology and pharmacology of aztreonam.
    Duma RJ
    Urology; 1988 Jun; 31(6 Suppl):9-13. PubMed ID: 3287750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
    Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
    Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila.
    Hohl P; von Graevenitz A; Zollinger-Iten J
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1593-4. PubMed ID: 3190188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
    Hoban DJ; Bouchillon SK; Johnson BM; Johnson JL; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):215-27. PubMed ID: 16105567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sensitivity of nonfermenting gram-negative bacteria of clinical origin to antibacterial preparations].
    Shchenderov BA; Serkova GP; Tiurin MV
    Antibiotiki; 1984 Mar; 29(3):191-5. PubMed ID: 6732205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.